News|Articles|November 29, 2024
Weekly review: Vaccine coverage, exemptions, and mRNA reactions
Author(s)Joshua Fitch, Senior Editor
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
Advertisement
Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, November 25, to Friday, November 29, 2024), and click on each link to read and watch anything you may have missed.
CDC confirms H5N1 bird flu infection in California child
The Centers for Disease Control and Prevention (CDC) has confirmed an infection of avian influenza A (H5N1; H5N1 bird flu) in a child in California, marking the first reported avian influenza H5 virus infection among a child in the United States.
The child reportedly experienced mild symptoms and received flu antivirals, consistent with previously infected human cases in the United States.
Kindergarten vaccine coverage decreased, exemptions increased in 2023-2024 school year
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief of Contemporary Pediatrics and professor of pediatrics at Northwestern University’s Feinberg School of Medicine, shared her concerns regarding rising vaccine hesitancy and unwarranted exemptions, emphasizing the importance of immunization in safeguarding public health.
“The increase in vaccine exemptions, many of them are not valid,” said Tan. “Vaccine hesitancy has definitely increased because vaccines during the COVID era have become politicized. So people believe that the vaccines either aren't effective or they don't trust the new way that vaccines are developed, and that's very unfortunate."
No unexpected reactions present in mRNA COVID-19 vaccination among kids
A new study demonstrated that there were no unexpected reactions to COVID-19 vaccination in a very young pediatric population (6 to 24 months old). These participants received at least 1 dose of either of the FDA approved mRNA COVID-19 vaccines (Pfizer-BioNTech or Moderna).
The most common reactions reported were the following: irritability or fussiness (30.1%), local reactions (21.1%) and fever (13.8%).
Background on whole genome sequencing and review of the GUARDIAN study
Paul Kruszka, MD, MPH, FACMG, chief medical officer at GeneDx and clinical geneticist at Children’s National Hospital, explained the role of genetic testing in improving pediatric care. Speaking on the potential of whole genome sequencing, Kruszka emphasized its value in diagnosing rare diseases earlier and more effectively.
“One out of 10 people in North America are affected by a rare disease, that’s 30 million people in the [United States],” Kruszka noted, highlighting the prevalence of rare genetic conditions. “There is a lot of genetic rare disease. So certainly, this is in the wheelhouse of a general pediatrician and all the pediatric sub-specialties, whether you’re a neonatologist, a pediatric neurologist, [or] a developmental pediatrician.”
Study: Concussions slow aperiodic activity among high school football players
According to the Centers for Disease Control and Prevention (CDC), approximately 7 of 10 emergency department (ED) visits for sports- and recreation-related traumatic brain injuries (TBI) and concussions are among children aged 17 years and younger, with boys having approximately twice the rate of ED visits compared to girls for similar injuries.
The CDC ranks boys tackle football as No. 1 on a list of top 10 sports with the highest rates of concussions. In the sport, the federal agency notes that tackling is responsible for nearly 2 out of 3 concussions, and that almost half of concussions occur during running plays.
Advertisement
Related to this article

The approval is based on BRAVE-AA-PEDS, in which 42% of adolescents receiving baricitinib 4 mg achieved at least 80% scalp hair coverage at week 36 vs 5% with placebo.

FDA approved obinutuzumab for relapsing or steroid-dependent childhood-onset INS, based on INShore data showing 95.5% vs 73.2% sustained remission.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Glucommander Pediatrics received FDA Breakthrough Device Designation for IV insulin dosing in hospitalized children younger than 2 years, but remains uncleared.

Jonathan Miller, MD, discusses earlier HPV vaccination, individualized conversations with hesitant families, and strategies to improve vaccine uptake.

Jonathan Miller, MD, discusses factors behind lagging HPV vaccination rates and how pediatricians can address common parent concerns.

In a Hirschsprung disease mouse model, diet shifted gut microbes and inflammation, with a 3-fold survival difference between standard diets.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves baricitinib for adolescents with severe alopecia areata
2
GLP-1 receptor agonists tied to nutritional deficiencies in children, study finds
3
FDA approves obinutuzumab to reduce relapse risk in childhood-onset idiopathic nephrotic syndrome
4
FAQ: How should pediatricians hand off teens with diabetes?
5

